Sean B. Carroll

First Person | Sean B. Carroll Courtesy of Howard Hughes Medical Institute Sean B. Carroll, developmental biologist, rock 'n' roll lover, a man who will stand in five feet of water all day dredging for shark teeth, is dreading his advancing years. He's all of 42. A self-described jeans-and-sneaker-wearing regular guy, Carroll says his age is "very hard to get used to. I don't know, it seems I've been doing this too long." Earning his PhD in immunology at the age of 22--which he attributes

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Sean B. Carroll, developmental biologist, rock 'n' roll lover, a man who will stand in five feet of water all day dredging for shark teeth, is dreading his advancing years. He's all of 42. A self-described jeans-and-sneaker-wearing regular guy, Carroll says his age is "very hard to get used to. I don't know, it seems I've been doing this too long."

Earning his PhD in immunology at the age of 22--which he attributes more to empty pockets and determination than brains--Carroll switched gears as a postdoc in the early 1980s, when the idea of studying evolution through development was beginning to make sense. "Paleontologists were interested in how form changed, but they couldn't say where form came from. It made me decide to study developmental genetics."

One hundred-plus papers, significant press attention, and more than 20 years later, Carroll, a Howard Hughes Medical Institute investigator, still loves his work at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies